San Diego, CA, United States of America

Robert Macleod

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ionis Pharmaceuticals, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Macleod. Retrieved from https://idiyas.com/inventor/robert-macleod-5u427rv7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert Macleod

Introduction

Robert Macleod is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in cancer research. His innovative work focuses on the modulation of MALAT1 expression, which has implications for cancer treatment.

Latest Patents

Robert Macleod holds a patent for "Modulators of MALAT1 expression." This patent provides methods, compounds, and compositions that are useful for inhibiting MALAT1 expression. The invention may be beneficial for treating, preventing, or ameliorating cancers associated with MALAT1.

Career Highlights

Robert Macleod is currently employed at Ionis Pharmaceuticals, Inc. His role at the company allows him to work on cutting-edge research and development in the biotechnology sector. His expertise and innovative mindset have contributed to advancements in therapeutic approaches for cancer.

Collaborations

Some of Robert's notable coworkers include Susan M Freier and Youngsoo Kim. Their collaborative efforts in research and development have further enhanced the impact of their work in the field.

Conclusion

Robert Macleod's contributions to biotechnology and cancer research exemplify the importance of innovation in addressing complex health challenges. His patent on MALAT1 expression modulation represents a significant step forward in cancer treatment strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…